The miR-34 Family and its Clinical Significance in Ovarian Cancer
The tumor suppressor miR-34 family is transcriptionally induced by p53. Clinical significance of...
Read More
Hematology/Oncology
Sharing Real-World Experiences to Optimize Management of Olaparib Toxicities
Olaparib is the first poly(ADP-ribose) polymerase inhibitor approved as maintenance therapy of...
Read More
Circular RNA PVT1 enhances cell proliferation but inhibits apoptosis through sponging microRNA-149 in epithelial ovarian cancer.
This study aimed to investigate the influence of circular RNA PVT1 (circ-PVT1) on epithelial...
Read More
Oral Metronomic Chemotherapy for Recurrent & Refractory Epithelial Ovarian Cancer
Advanced epithelial ovarian cancer (EOC) is associated with dismal outcome and progression-free...
Read More
LncRNA TTN-AS1 acts as sponge for miR-15b-5p to regulate FBXW7 expression in ovarian cancer.
Emerging evidence showed that long noncoding RNA (lncRNA) plays crucial roles in regulating...
Read More
Ubiquitin-specific protease 14 regulates ovarian cancer cisplatin-resistance by stabilizing BCL6 oncoprotein.
Ubiquitin-specific protease 14 (USP14) is one of the three proteasome-associated deubiquitinating...
Read More
Endoplasmic Reticulum Stress Proteins in Ovarian Carcinoma
Epithelial ovarian cancer (EOC) is a leading cause of cancer-related mortality in the United...
Read More
microRNA-141-3p-containing small extracellular vesicles derived from epithelial ovarian cancer cells promote endothelial cell angiogenesis through activating the JAK/STAT3 and NF-κB signaling pathways.
Paracrine signaling between tumor and surrounding stromal cells is critical for the maintenance of...
Read More
Synergistic Antitumor Effects in Drug-Resistant Ovarian Cancer
Despite the promising anticancer effects of kinesin spindle protein (KSP) inhibition, functional...
Read More
Knockdown of enhancer of rudimentary homolog inhibits proliferation and metastasis in ovarian cancer by regulating epithelial-mesenchymal transition.
Ovarian cancer (OC) is the deadliest gynecological malignancy. The pathogenesis of molecular in...
Read More
Loss of hnRNPA2B1 inhibits malignant capability and promotes apoptosis via down-regulating Lin28B expression in ovarian cancer.
Ovarian cancer has the highest mortality rate among all gynecological cancers with its pathogenic...
Read More
Coping with Fear of Cancer Recurrence Among Ovarian Cancer Survivors
Fear of cancer recurrence (FCR) is a paramount concern among ovarian cancer survivors. Evidence...
Read More
Long non-coding RNA TTN-AS1 promotes tumorigenesis of ovarian cancer through modulating the miR-139-5p/ROCK2 axis.
Long non-coding RNA (lncRNA) TTN antisense RNA 1 (TTN-AS1) was reported to be crucial modulators...
Read More
Histological Tumor Type is Associated with One-Year Cause-Specific Survival in Women with Stage III-IV Epithelial Ovarian Cancer: A Surveillance, Epidemiology, and End Results (SEER) Database Population Study, 2004-2014.
BACKGROUND The prognosis of epithelial ovarian cancer (EOC) remains poor. Cause-specific survival...
Read More
Poor Perfusion of Microvasculature in Peritoneal Metastases of Ovarian Cancer
Most women with epithelial ovarian cancer (EOC) suffer from peritoneal carcinomatosis upon first...
Read More
The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation.
N 6-Methyladenosine (m6A) is the most abundant RNA modification in mammal mRNAs and increasing...
Read More
Proteomic analysis of degradation ubiquitin signaling by ubiquitin occupancy changes responding to 26S proteasome inhibition.
Ubiquitination is a post-translational modification where ubiquitin is covalently attached to...
Read More
Genomic Signatures of Immune Activation Predict Outcome in Advanced Stages of Ovarian Cancer and Basal-Like Breast Tumors.
There is an unmet need for new therapies in metastatic ovarian cancer and basal-like breast cancer...
Read More
Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer.
Sarcopenia is commonly observed in patients with advanced-stage epithelial ovarian cancer (EOC)....
Read More
Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation.
Ovarian cancer is one of the most common malignant tumors of the female reproductive system, which...
Read More